Holen Sie sich die Stockscreener-App
28.72
9.24%
-2.94
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
HIMS Looks 20.9% Undervalued on GF Value™ Despite Credit Dispute Penalties - GuruFocus
Hims & Hers Health Inc (HIMS) Shares Surge 6.0% -- What GF Score of 82 Tells Investors - GuruFocus
Hims & Hers Health facing penalties from Visa for credit card disputesreport - Seeking Alpha
Hims & Hers faces Visa penalties over dispute surgeBloomberg By Investing.com - Investing.com Canada
HIMS Stock Has Quadrupled In 5 Years: How Hims Turned A $3 Stock Into A Telehealth Giant - Stocktwits
Hims’ Weight-Loss Plans Draw Penalties Over Credit Card Disputes - Bloomberg.com
Hims & Hers Health (HIMS) Stock Falls 14.73% After FTC Lawsuit; Law Firm Launches Securities Investigation - kalkine.ca
Bragar Eagel & Squire, P.C. is Investigating Hims & Hers - GlobeNewswire
HIMS Maintained by Barclays -- Price Target Lowered to $35 - GuruFocus
Barclays Issues Pessimistic Forecast for Hims & Hers Health (NYSE:HIMS) Stock Price - MarketBeat
HIMS Stock More Than Doubled in 6 Months: What's Driving the Rally? - TradingView
Hims & Hers Health Inc (HIMS) Chief Legal Officer Soleil Boughto - GuruFocus
Hims & Hers Health (HIMS) & Novo Nordisk A/S (NVO): Two Weight-Loss Pill Players Just Got Punished for Growing Fast - Yahoo Finance
Hims & Hers Health (NYSE:HIMS) CFO Oluyemi Okupe Sells 4,938 Shares - MarketBeat
Hims & Hers Health (NYSE:HIMS) Insider Soleil Boughton Sells 25,111 Shares of Stock - MarketBeat
Hims & Hers Health (NYSE:HIMS) Insider Deborah Autor Sells 16,773 Shares - MarketBeat
Hims & Hers (NYSE: HIMS) policy chief sells shares under 10b5-1 plan - Stock Titan
Hims & Hers Health Options Spot-On: On August 20th, 143.18K Contracts Were Traded, With 928.8K Open Interest - Moomoo
Hims & Hers Health Stock Trades Below The Market On Revenue And Above It On Cash - Trefis
Hims & Hers faces federal lawsuit and price tar... - Pluang
Barclays cuts Hims and Hers stock price target on margin pressure - Investing.com Canada
Hims & Hers Stock Jumped 14% Yesterday. The CEO’s CNBC Interview Is Why. - TIKR.com
Hims & Hers Health (NYSE: HIMS) CEO Disposes Of 78,859 Shares In Routine Tax Withholding Event - foreignpolicyjournal.com
FTC, California and Utah Sue Telehealth Company Hims & Hers for Deceptive and Unlawful Privacy Practices - Hunton Andrews Kurth LLP
Hims & Hers CEO Defends Data Practices, Projects Sharp Drop in Weight-Loss Drug Prices - finance.biggo.com
Hims & Hers Health (NYSE:HIMS) Stock Price Up 10.8%What's Next? - MarketBeat
Hims & Hers CFO Sells $3.2 Million in Stock Amid Leadership Transition - finance.biggo.com
Hims & Hers Rejects Privacy Allegations While Promising Expanded Patient Access - Benzinga
Hims & Hers Health sees 17x international reven... - Pluang
Wellness Briefing: Hims & Hers plots rapid expansion into peptide therapies like BPC-157, plus news - glossy.co
Hims & Hers: Buying The Margin Dip (NYSE:HIMS) - Seeking Alpha
Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (HIMS) - marketscreener.com
Hims & Hers' Chief Accounting Officer Is Leaving. Here's What Her Latest Insider Filing Shows - The Motley Fool
An Insider at Hims & Hers Just Filed. Here's What It Says About Buying the Dip - The Motley Fool
What Long-Term Investors Should Know About This Hims Insider Filing - The Motley Fool
A Hims & Hers Insider Disposed of Stock as the Company Pushes Into Testosterone and Peptides. Here's What to Know - The Motley Fool
Hims & Hers' Policy Chief Just Filed an Insider Transaction. Here's What It Means. - The Motley Fool
An Insider at Hims & Hers Disposed of Over $3 Million in Stock. Here's What Long-Term Investors Should Know - The Motley Fool
The CTO of Hims & Hers Just Gave Up Nearly $2.7 Million in Stock. Here's What It Actually Means - The Motley Fool
Hims & Hers' CEO Just Disposed of 78,859 Shares. Here's What Long-Term Investors Should Know. - The Motley Fool
An Insider at Hims & Hers Just Filed. Here's What It Says About Buying the Dip - The Motley Fool
Companies with huge datasets can save up to 80% in AI costs by using open-weight models: Hims CEO - Business Insider
Hims & Hers Health Boosts Revenue Target, Swings to Second-Quarter Loss - wsj.com
Hims & Hers faces FTC lawsuit over privacy brea... - Pluang
Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm - PR Newswire
Is Hims & Hers Health Inc (HIMS) a Bargain After 4.3% Drop? GF V - GuruFocus
Why Is Hims & Hers Health (HIMS) Facing A New Privacy Lawsuit? - Yahoo Finance
Oluyemi Okupe Sells 55,383 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells $261,831.32 in Stock - MarketBeat
Hims & Hers Health (NYSE: HIMS) Stock Plunges 14% Following - GlobeNewswire
Hims & Hers CEO Andrew Dudum Says AI Health Coach Could Be Just 12 Months Away, Believes It Could Increase Medication Adherence - Stocktwits
Kaplan Fox Announces an Investigation Into Hims & Hers Health, In - The National Law Review
Hims & Hers Health Options Spot-On: On August 18th, 65,547 Contracts Were Traded, With 886.89K Open Interest - Moomoo
HIMS Looks 34.0% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
HIMS Stock Climbs Overnight: Oscar Health CEO Courts Hims For New Drug Marketplace - Stocktwits
Hims CEO responds to FTC suit, sees GLP-1 prices falling to $40-$50: CNBC - Seeking Alpha
Hims & Hers CEO Andrew Dudum pushes back on FTC lawsuit - qz.com
Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors" - Investing.com Nigeria
Hims & Hers CEO Tells the FTC That Regulators Just Don’t Understand - Yahoo Finance
2.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):